Reportable Segments (Tables)

12 Months Ended

Jul. 31, 2019

Segment Reporting [Abstract]

Information as to operating segments

Information as to reportable segments is summarized below:

	Year Ended July 31,
	2019		2018		2017
Net sales:
Medical	$	523,669	$	473,937	$	398,773
Life Sciences (1)	201,022		217,030		196,446
Dental (1)	161,608		149,360		144,457
Dialysis	31,856		31,595		30,481
Total	$	918,155	$	871,922	$	770,157

_______________________________________________

(1) In fiscal 2018, approximately $5,820 of net sales were reclassified out of our Dental segment and into our Life Sciences segment associated with the changes in our segments noted above. Fiscal 2017 amounts were not material and were not adjusted.

	Year Ended July 31,
	2019			2018			2017
Income from operations:
Medical	$	98,356		$	86,833		$	73,440
Life Sciences (1)	20,552			36,803			33,159
Dental (1)	22,289			30,004			28,000
Dialysis	4,922			7,380			8,154
	146,119			161,020			142,753
General corporate expenses	62,600			39,356			32,343
Income from operations	83,519			121,664			110,410
Interest expense, net	9,505			5,289			4,303
Other income	(1,305		)	(1,138		)	(126		)
Income before income taxes	$	75,319		$	117,513		$	106,233

_______________________________________________

(1) In fiscal 2018, approximately $1,704 of income from operations were reclassified out of our Dental segment and into our Life Sciences segment associated with the changes in our segments noted above. Fiscal 2017 amounts were not material and were not adjusted.

	July 31,
	2019		2018
Identifiable assets:
Medical	$	532,250	$	490,702
Life Sciences	184,737		151,460
Dental	272,309		210,831
Dialysis	19,016		22,614
General corporate, including cash and cash equivalents	62,054		88,101
Total	$	1,070,366	$	963,708

	Year Ended July 31,
	2019		2018		2017
Capital expenditures:
Medical	$	52,907	$	18,996	$	13,816
Life Sciences	16,408		4,409		3,689
Dental	16,243		2,441		2,492
Dialysis	3,203		644		1,296
General corporate	6,677		11,208		5,772
Total	$	95,438	37,698		27,065

	Year Ended July 31,
	2019		2018		2017
Depreciation and amortization:
Medical	$	23,033	$	19,002	$	18,245
Life Sciences	7,482		5,628		5,706
Dental	9,844		8,756		8,556
Dialysis	39		711		427
General corporate	1,961		733		518
Total	$	42,359	$	34,830	$	33,452

Information as to geographic areas

Information as to geographic areas (including net sales which represent the geographic area from which we derive its net sales from external customers) is summarized below:

	Year Ended July 31,
	2019		2018		2017
Net sales:
United States	$	665,661	$	643,744	$	599,657
Europe/Africa/Middle East	148,334		131,130		95,753
Asia/Pacific	66,228		57,108		40,964
Canada	32,152		33,524		26,648
Latin America/South America	5,780		6,416		7,135
Total	$	918,155	$	871,922	$	770,157

	July 31,
	2019		2018
Total long-lived assets:
United States	$	128,010	$	80,918
Europe/Africa/Middle East	64,742		35,824
Asia/Pacific	4,201		2,531
Canada	1,995		804
Total	198,948		120,077
Goodwill and intangible assets, net	519,622		505,388
Total	$	718,570	$	625,465